BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33735269)

  • 1. Assembly assay identifies a critical region of human fibrillin-1 required for 10-12 nm diameter microfibril biogenesis.
    Jensen SA; Atwa O; Handford PA
    PLoS One; 2021; 16(3):e0248532. PubMed ID: 33735269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel fibrillin-1 gene missense mutation associated with neonatal Marfan syndrome: a case report and review of the mutation spectrum.
    Peng Q; Deng Y; Yang Y; Liu H
    BMC Pediatr; 2016 Apr; 16():60. PubMed ID: 27138491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A microfibril assembly assay identifies different mechanisms of dominance underlying Marfan syndrome, stiff skin syndrome and acromelic dysplasias.
    Jensen SA; Iqbal S; Bulsiewicz A; Handford PA
    Hum Mol Genet; 2015 Aug; 24(15):4454-63. PubMed ID: 25979247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the structure, assembly and biological roles of 10-12 nm connective tissue microfibrils from fibrillin-1 studies.
    Jensen SA; Handford PA
    Biochem J; 2016 Apr; 473(7):827-38. PubMed ID: 27026396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steered molecular dynamic simulations reveal Marfan syndrome mutations disrupt fibrillin-1 cbEGF domain mechanosensitive calcium binding.
    Haller SJ; Roitberg AE; Dudley AT
    Sci Rep; 2020 Oct; 10(1):16844. PubMed ID: 33033378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo studies of mutant fibrillin-1 microfibrils.
    Charbonneau NL; Carlson EJ; Tufa S; Sengle G; Manalo EC; Carlberg VM; Ramirez F; Keene DR; Sakai LY
    J Biol Chem; 2010 Aug; 285(32):24943-55. PubMed ID: 20529844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double mutant fibrillin-1 (FBN1) allele in a patient with neonatal Marfan syndrome.
    Wang M; Kishnani P; Decker-Phillips M; Kahler SG; Chen YT; Godfrey M
    J Med Genet; 1996 Sep; 33(9):760-3. PubMed ID: 8880577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel exon skipping mutation in the fibrillin-1 gene: two 'hot spots' for the neonatal Marfan syndrome.
    Booms P; Cisler J; Mathews KR; Godfrey M; Tiecke F; Kaufmann UC; Vetter U; Hagemeier C; Robinson PN
    Clin Genet; 1999 Feb; 55(2):110-7. PubMed ID: 10189088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome.
    Liu W; Qian C; Comeau K; Brenn T; Furthmayr H; Francke U
    Hum Mol Genet; 1996 Oct; 5(10):1581-7. PubMed ID: 8894692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Throughput Genomics Identify Novel
    Zodanu GKE; Hwang JH; Mehta Z; Sisniega C; Barsegian A; Kang X; Biniwale R; Si MS; Satou GM; Halnon N; Ucla Congenital Heart Defect BioCore Faculty ; Grody WW; Van Arsdell GS; Nelson SF; Touma M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel large in-frame
    Elgaz S; Wittekindt B; Esmaeili A; Fischer S; Bolz HJ; Zechner U; Buxmann H
    Cold Spring Harb Mol Case Stud; 2022 Oct; 8(6):. PubMed ID: 36307213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.
    Sakai LY; Keene DR; Renard M; De Backer J
    Gene; 2016 Oct; 591(1):279-291. PubMed ID: 27437668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTSL6β promotes fibrillin-1 microfibril assembly, which is possibly mediated via binding through the third thrombospondin type I domain to fibrillin-1.
    Orimoto A; Fukuda T
    Cell Biol Int; 2020 Jul; 44(7):1436-1446. PubMed ID: 32141660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the assembly of extracellular microfibrils from the analysis of the fibrillin 1 mutation in the tight skin mouse.
    Gayraud B; Keene DR; Sakai LY; Ramirez F
    J Cell Biol; 2000 Aug; 150(3):667-80. PubMed ID: 10931876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recapitulating and Correcting Marfan Syndrome in a Cellular Model.
    Park JW; Yan L; Stoddard C; Wang X; Yue Z; Crandall L; Robinson T; Chang Y; Denton K; Li E; Jiang B; Zhang Z; Martins-Taylor K; Yee SP; Nie H; Gu F; Si W; Xie T; Yue L; Xu RH
    Int J Biol Sci; 2017; 13(5):588-603. PubMed ID: 28539832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adamtsl2 deletion results in bronchial fibrillin microfibril accumulation and bronchial epithelial dysplasia--a novel mouse model providing insights into geleophysic dysplasia.
    Hubmacher D; Wang LW; Mecham RP; Reinhardt DP; Apte SS
    Dis Model Mech; 2015 May; 8(5):487-99. PubMed ID: 25762570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical and neonatal Marfan syndrome mutations in fibrillin-1 cause differential protease susceptibilities and protein function.
    Kirschner R; Hubmacher D; Iyengar G; Kaur J; Fagotto-Kaufmann C; Brömme D; Bartels R; Reinhardt DP
    J Biol Chem; 2011 Sep; 286(37):32810-23. PubMed ID: 21784848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders.
    Whiteman P; Handford PA
    Hum Mol Genet; 2003 Apr; 12(7):727-37. PubMed ID: 12651868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular pathogenesis of the Marfan syndrome.
    Robinson PN; Booms P
    Cell Mol Life Sci; 2001 Oct; 58(11):1698-707. PubMed ID: 11706995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable severity of cardiovascular phenotypes in patients with an early-onset form of Marfan syndrome harboring FBN1 mutations in exons 24-32.
    Maeda J; Kosaki K; Shiono J; Kouno K; Aeba R; Yamagishi H
    Heart Vessels; 2016 Oct; 31(10):1717-23. PubMed ID: 26796135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.